Groups
|
pD2
|
Emax
|
---|
Control
|
HFD
|
Control
|
HFD
|
---|
C57Bl/6J (acetylcholine)
|
7.29 ± 0.06 (n = 6)
|
6.80 ± 0.04 (n = 6)*
|
92.8 ± 1.9 (n = 6)
|
59.9 ± 1.8 (n = 6)*
|
TNF-α−/− (acetylcholine)
|
7.16 ± 0.02 (n = 6)
|
6.94 ± 0.04 (n = 6)#
|
94.4 ± 2.1 (n = 6)
|
87.8 ± 1.3 (n = 6)#
|
C57Bl/6J (insulin)
|
7.01 ± 0.15 (n = 5)
|
6.02 ± 0.18 (n = 6)*
|
80.8 ± 2.7 (n = 5)
|
52.8 ± 6.8 (n = 5)*
|
TNF-α−/− (insulin)
|
6.84 ± 0.51 (n = 5)
|
6.91 ± 0.20 (n = 6)#
|
84.4 ± 2.1 (n = 5)
|
86.7 ± 2.9 (n = 5)#
|
C57Bl/6J_Infliximab
|
7.03 ± 0.14 (n = 5)
|
6.69 ± 0.21 (n = 6)#
|
85.0 ± 1.8 (n = 5)
|
63.7 ± 2.2 (n = 5)*
|
- Data represent the mean ± SEM of n experiments. Two-way ANOVA with Bonferroni post-test. * p < 0.05 vs. C57Bl/6J Control; # p < 0.05 vs. C57Bl/6J HFD